project id: TCGA-BRCA; case submitter id: TCGA-AN-A03X; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 74; days to birth: -27163; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 27163; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 10.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; creation datetime: 1276473600.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 36; initial weight: 170.0; sample id: d9e29db0-558c-4bd5-aa94-15d5d57110b1; sample submitter id: TCGA-AN-A03X-01A; portion id: ed8e0ca2-d3ba-4d35-a20b-49be9a818102; portion submitter id: TCGA-AN-A03X-01A-21; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 19.0; percent tumor cells: 80.0;